Solesence, Inc. Common Stock logo

Solesence, Inc. Common Stock(SLSN)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$1.52
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SLSN

11/13/2026: SLSN (1-star) is currently NOT-A-BUY. Pass it for now.

Solesence, Inc. is a small-cap, science-driven company that specializes in developing and manufacturing mineral-based skincare and sun protection products for beauty brands. The company leverages its proprietary Active Stress Defense™ technology to provide turnkey solutions that are highly regarded for prestige beauty applications. While its shift into high-growth beauty segments provides a promising narrative, the company continues to manage inconsistent profitability and the execution risks inherent in scaling. Investors should weigh this growth potential against significant price volatility and competition within the personal care space. Solesence is generally suited for growth-oriented investors who can tolerate micro-cap risks, provided they monitor the company’s ability to achieve consistent operational scale.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company offers high growth potential in prestige beauty but currently lacks consistent profitability.
Momentum investorWeak fitThe stock has seen significant price depreciation, making it unsuitable for momentum strategies without a clear upturn.
Value investorWeak fitCurrent valuation metrics and operating losses do not support a traditional value-based thesis.
Dividend investorWeak fitThe company does not pay a dividend and is focused on reinvesting cash for growth.
Low-risk investorWeak fitHigh price volatility and negative earnings profile present significant risk for conservative investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock is a micro-cap with significant price fluctuations influenced by limited liquidity.
Valuation riskHighNegative earnings and a volatile track record make traditional valuation difficult.
Competition risk (beauty manufacturing)Medium / highIntense pressure from larger, better-funded manufacturers and incumbents limits pricing power.
Business qualityMediumWhile the technology is innovative, the company is still building a consistent track record of operational efficiency.
Dividend incomeLow / noneThe company is a growth-oriented business that does not provide income to investors.
Execution riskMedium / highScaling manufacturing while maintaining consistent profitability is critical to long-term survival.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 107.38M USD
Price to earnings Ratio 50.67
1Y Target Price -
Price to earnings Ratio 50.67
1Y Target Price -
Volume (30-day avg) 661.9K shares
Beta 1.37
52 Weeks Range 0.61 - 2.30
Updated Date 11/14/2026
52 Weeks Range 0.61 - 2.30
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.03

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Household & Personal Products

BUY participation
100.0%
Active BUY / eligible
2 / 2
30-Day BUY Count Change
+1

Eligible universe: 2 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -43.33%
Avg. Invested days 16
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SLSN receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, and soft analyst coverage.

Company Fundamentals

★★★★★
SLSN has moderate overall fundamentals (3 stars), with moderate financial health, soft growth momentum, and moderate ownership. In FY2025 versus FY2024, solid revenue growth (+18.6%) is partially offset by negative earnings growth (-57.7%), weak cash generation (FCF margin -17.3%), soft profitability (net margin 2.9%).

Financial Health Rating

★★★★★
SLSN's financial health is supported by moderate liquidity, including working-capital and asset support (WC/assets 29.7%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is SLSN's strongest growth driver at +18.6% FY2025 versus FY2024 (solid, 4 stars). By comparison, while earnings growth (-57.7%, negative) and free-cash-flow growth (-314.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 5.4% (soft) and 25.9% of outstanding shares are publicly tradable (soft). Insider ownership of 73.09% supports management-shareholder alignment.

Top 5 Institutional Investors

Vanguard Capital Management, LLC 1.18%
BlackRock Inc 0.66%
Bank of New York Mellon Corp 0.45%
Millennium Management LLC 0.39%
Geode Capital Management, LLC 0.34%

Unit Economics (Per $1K Revenue)

★★★★★
SLSN generates approximately $258 of gross profit, $25 of operating income, and $-173 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Negative free cash flow explains the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 3.92%

Quantitative Style Profile

★★★★★
SLSN has a High Volatility Profile profile. Valuation that is moderately attractive rather than deeply discounted is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

High VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Beauty Science SkincareTurnkey prestige formulations and custom product development for skin health brands.The company gets paid to develop and manufacture high-end skincare for other brands.
Advanced Materials / APIsSales of proprietary zinc and titanium dioxide ingredients used in sunscreens.Solesence sells its specialized 'secret sauce' ingredients to other cosmetic manufacturers.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-12
When After Market
Estimate -
Actual 0.05

Profitability

Profit Margin -5.25%
Operating Margin (TTM) -3.62%

Management Effectiveness

Return on Assets (TTM) -2.35%
Return on Equity (TTM) -18.55%

Valuation

Trailing PE 50.67
Forward PE 11.36
Enterprise Value 85.24M
Price to Sales(TTM) 1.94
Enterprise Value 85.24M
Price to Sales(TTM) 1.94
Enterprise Value to Revenue 1.54
Enterprise Value to EBITDA 27.69
Shares Outstanding 70.65M
Shares Floating 18.33M
Shares Outstanding 70.65M
Shares Floating 18.33M
Percent Insiders 73.09
Percent Institutions 5.36

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.